Skip to main content
AdvisorShares Psychedelics ETF—— (—)Compass Pathways—— (—)Definium Therapeutics—— (—)GH Research—— (—)Helus Pharma—— (—)MIRA Pharmaceuticals—— (—)Neuphoria Therapeutics—— (—)Eli Lilly—— (—)Johnson & Johnson—— (—)AbbVie—— (—)Otsuka Pharmaceutical—— (—)Numinus Wellness—— (—)Optimi Health—— (—)PharmAla Biotech—— (—)Enveric Biosciences—— (—)Incannex Healthcare—— (—)Aurora Cannabis—— (—)Cronos Group—— (—)SNDL—— (—)Bright Minds Biosciences—— (—)PharmaTher Holdings—— (—)IM Cannabis—— (—)MariMed—— (—)Vireo Growth—— (—)
Loading prices

Professional Development

How journalism faces a second wave of disruption from technology and changing audience behaviour

A folded newspaper transitions into a tablet, surrounded by abstract audience silhouettes and connected digital shapes.

How journalism faces a second wave of disruption from technology and changing audience behaviour, with Nic Newman, Research Associate, Reuters Institute. This Professional Development event from the Reuters Institute for the Study of Journalism takes place on 29 October 2014 in the Barclay Room, Green Templeton College.

Hosted with: Psychedelic Writers Guild